Richard Armitage
Analyst · Investec
Thank you, Damien, and good morning, everyone. I'm going to start with an overview of the financial results for the 6 months to the 30th of June 2026. Revenue was GBP 518 million, an increase of 4.8% on an organic constant currency basis, resulting from growth in our Aerospace and Energy end markets. Our revenue includes a GBP 8.9 million phasing benefit from a take-or-pay arrangement with one of our semiconductor customers, which will not repeat in H2. If we exclude this phasing benefit, revenue grew by 3% on a constant currency basis. Group headline adjusted operating profit was GBP 57.8 million, giving an adjusted operating margin of 11.2%. Operating margin also reflects the GBP 8.9 million phasing benefit without which it would have been 9.6% Return on invested capital was 14.5%, slightly below our through-cycle [indiscernible] trajectory. Free cash flow saw an inflow of GBP 3.5 million, broadly in line with the first half of 2025 and reflecting the investments we continue to make into the group. Adjusted EPS was 10.7p per share, and we have held the interim dividend flat at 5.4p. Specific adjusting items amounted to GBP 18.4 million for the half year, driven primarily by expenditure on the implementation of our group-wide ERP system. Turning to look at the reporting segments in more detail. We can see the Performance Carbon revenue increased by 4% on a constant currency basis, which includes the GBP 8.9 million take-or-pay revenue. This take-or-pay contract related to the reduction in our outlook for semiconductor revenue that we announced during the second half of 2025 arising from the sourcing of certain products moving to China. Whilst we had expected to supply these products during the second half of 2026, the customer has settled their contractual equipments in full during the first half. Excluding this phasing item, revenue declined by 1.8% versus the prior year with strong growth in energy, notably in wind, more than offset by reduced demand for body armour and industrial equipment. As has been seen before, the demand for body armour is driven by uneven government procurement patterns, and we do expect to see an increase in demand going into 2027 with new products being launched. We would also note some caution around the outlook within our European industrial segments, where we are starting to see slightly softer demand. Margin improved by 70 basis points, driven by the GBP 8.9 million take-or-pay income, which will not repeat in H2. Excluding this item, margin showed a deterioration caused primarily by the lower Armour sales. Technical Ceramics saw strong growth during the first half, growing 7.8% on a constant currency basis. The main growth driver continues to be aerospace and defense with growth driven by demand for ceramic cores, a critical component in the manufacture of jet engine turbine blades. Aerospace and Defense now accounts for 39% of divisional revenues following strong growth over the last few years. We also saw strong growth in energy, driven by increasing demand for industrial gas turbines to power data centers. Operating margin improved by 130 basis points to 13%, mainly due to a strong drop-through on revenue growth. We have spoken before of the opportunity for revenue growth to help drive margin expansion in this way, which was clearly demonstrated by Technical Ceramics in the first half. Thermal Products returned to growth during the first half of 2026, showing 2.5% growth on a constant currency basis. We saw a strong performance in Asia, driven by growth in metals processing in India and China. In North America, increased CPI project revenue and demand for our innovative energy storage solutions also supported growth. However, European revenue is being impacted by weaker investment in Process Industries attributed to the geopolitical environment. Coming into the year, we did experience a number of operational challenges arising mainly from equipment failures in our main North American facility affecting margin. These have been addressed, and we are starting to see a steady improvement in performance. Turning now to our profit margin bridge. We have attempted to illustrate the movement firstly from the first half of last year to the second and then from the second half of last year to the first half of this year. The comparison from H1 to H2 of last year was firstly driven by a number of one-off items in the first half that did not repeat in the second. However, the principal driver was volume and mix where we saw a sharp decline in demand from industrial markets as well as declines in revenue from Armour, semiconductor and health care that affected our margin mix. We have then started to see a solid improvement in margin this year, driven by a 250 basis point contribution from efficiency and simplification, which substantially reversed the decline in the second half of last year. We did experience some operational issues earlier in the year, primarily affecting Thermal Ceramics as noted. I would also note that we have successfully offset inflation through pricing of around 2% as is our usual practice. Finally, the payment under a take-or-pay agreement added 160 basis points to margin. Excluding this, operating margin in our first half would have been 9.6%, a significant improvement over the second half of last year and a result that gives us confidence in being able to make further progress towards our target of 12% margin by 2028. Moving to specific adjusting items. In the first half, we incurred costs of GBP 18.4 million. Restructuring costs of GBP 9.4 million include the costs associated with the closure of a Technical Ceramics site in the U.S. This investment will allow us to optimize margin over the longer term, and Damien will talk more about our site turnaround plans, which are progressing well. Once completed, this closure will bring our simplification program to an end, delivering a total annual run rate of GBP 27 million of ongoing cost benefits for an implementation cost of GBP 45 million. The work we have done to reduce our manufacturing cost base over the last 3 years, coupled with our planned optimization opportunities will accelerate margin improvement via a healthy drop-through as end markets recover. This will support the achievement during 2028 of our 12% margin target. Expenditure on our ERP rollout plan has progressed as planned with GBP 11.5 million incurred on configuration and implementation in the period. We expect to incur between GBP 22 million and GBP 24 million of total spend during 2026 before the program starts to wind down towards the end of 2027. We have also recorded a gain in the fair value of our shares in Foseco India Limited as at 30th of June of GBP 2.5 million, which values our holding at GBP 49 million. Moving on to cash flow. I would firstly note that working capital showed an outflow of GBP 23.5 million during the period, reflecting normal first half seasonality. We expect this to substantially reverse during the second half. Net capital expenditure amounted to GBP 12.5 million, significantly lower than the prior year as our investment in semiconductor capacity came to an end and due to the phasing of spend on certain other projects. Exceptional items totaled GBP 15.2 million, and free cash flow was therefore an inflow of GBP 3.5 million. Cash flow includes a further GBP 4.4 million benefit from supplier financing and nonrecourse debt factoring programs, which totaled GBP 42.6 million at the 30th of June. Net debt finished at GBP 253 million, excluding lease liabilities, in line with our expectations and representing 2x EBITDA. We anticipate that leverage will improve during the second half as free cash flow continues to normalize and as we realize the proceeds from the disposal of our shares in Foseco India. As a result of this, we expect year-end leverage to be around 1.7x. As a reminder of our capital allocation policy, our target leverage remains in the 1 to 1.5x range in relation to ongoing operations, which we will make progress towards reaching over the next 12 months. As before, once our leverage is within this range, we would consider a temporary increase into the 1.5 to 2x range in the event of a compelling acquisition. Whilst capital investment remains a priority to support organic growth opportunities, we foresee limited needs for capacity investment and expect to be able to maintain overall CapEx at around GBP 50 million or 1.2x depreciation for the next 3 years. We will maintain the dividend for now and grow it in line with adjusted earnings once capital returns to around 2.5x. Once stabilized, we will consider the need to fund inorganic investments alongside additional returns to shareholders. The Board will review the situation regularly, recognizing the opportunity that additional returns present to return cash to shareholders and enhance earnings. Now I will move on to technical guidance. Simplification costs for 2026 are expected to amount to around GBP 10 million, bringing the program to a close. ERP expenditure is expected to be in the range of GBP 22 million to GBP 24 million. We continue to expect capital expenditure of around GBP 50 million during 2026 weighted to the second half due to phasing. Our net finance charge will be around GBP 24 million, increasing on the prior year in part due to the expiry of GBP 94 million of fixed debt during the year on which we have been paying an average interest rate of 3%. Our effective tax rate is expected to be in the 27% to 29% range due to our geographic mix of profitability. We expect year-end leverage to be around 1.7x, showing a positive trajectory towards our target range of 1 to 1.5x. It is worth highlighting that with our simplification and ERP programs coming to an end in 2027 and with capital expenditure expected to remain close to 1x depreciation in the medium term, we expect to be generating positive free cash flow by the end of 2027. Finally, I will move on to the outlook for 2026. We are mindful of the current geopolitical and macroeconomic environment, particularly within European industrial markets. We, therefore, expect organic constant currency revenue growth of around 2% for the full year. Noting also a headwind due to foreign exchange, we expect an adjusted operating profit margin for the second half broadly in line with that of the first, excluding the GBP 8.9 million phasing benefit from the take-or-pay agreement. Thank you. And I would now like to hand back to Damien.